Physician profile

Jeffrey Evans

Pulmonary Disease · Oxford, MS

NPI 1053414326

$20,890.08

in general payments reported to CMS, 2019-2025

51 companies · $3,830 in 2025

The $3,830 reported for 2025 was more than what 86% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$7,340.62
Education$7,189.98
Travel and Lodging$1,283.50

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Intuitive Surgical, INC. $7,972.19 2024-2025
Glaxosmithkline, LLC. $1,937.25 2019-2025 Nucala, Trelegy Ellipta, Arexvy
Inspire Medical Systems, INC. $1,558.16 2022-2025 Inspire
Harmony Biosciences LLC $1,094.34 2020-2025 Wakix
Boehringer Ingelheim Pharmaceuticals, INC. $988.26 2019-2025 Ofev, Spiriva Respimat, Jascayd
Medical Device Business Services, INC. $846.32 2025 Monarch
Astrazeneca Pharmaceuticals LP $681.17 2019-2025 Airsupra, Breztri, Tezspire
Insmed, INC. $658.69 2019-2025 Arikayce, Brinsupri
Regeneron Healthcare Solutions, INC. $615.51 2019-2025 Dupixent
Genzyme Corporation $508.90 2019-2025
Ethicon INC. $434.36 2021-2023 Monarch Platform
Mylan Specialty L.P. $364.64 2019-2024 Yupelri
Grifols USA, LLC $286.50 2023-2025 Prolastin-C Liquid
Merck Sharp & Dohme LLC $276.20 2019-2025 Zerbaxa, Keytruda, Recarbrio
Mallinckrodt Hospital Products INC. $235.80 2020-2024 Acthar
Show all 51 companies
CompanyGeneral paymentsYearsTop products
Takeda Pharmaceuticals U.S.A., INC. $169.28 2023-2025 Glassia
Electromed, INC. $162.50 2019-2025 Smartvest
Actelion Pharmaceuticals US, INC. $161.44 2019-2023 Opsumit, Uptravi
Viatris Specialty LLC $150.20 2025 Yupelri
Genentech USA, INC. $147.79 2019-2023 Xolair
Sunovion Pharmaceuticals INC. $130.12 2019-2020
Cumberland Pharmaceuticals, INC. $112.65 2022
Bayer Healthcare Pharmaceuticals INC. $109.83 2023-2025
Verona Pharma, INC. $100.23 2025 Ohtuvayre
Fisher & Paykel Healthcare INC $99.03 2020-2024 Fisher & Paykel Healthcare
Novartis Pharmaceuticals Corporation $96.18 2019-2020
Portola Pharmaceuticals, LLC $87.62 2019-2020
Mallinckrodt Enterprises LLC $85.95 2019
Medtronic, INC. $85.00 2023-2024 Illumisite, Arcpoint
Janssen Pharmaceuticals, INC $76.48 2019-2021
Philips North America LLC $65.28 2019-2025 Vest Therapy Und
Baxter Healthcare $63.88 2023 Hillrom - Life 2000 Ventilation System
Pfizer INC. $51.90 2022-2024
Advanced Respiratory, INC $42.52 2019-2021
United Therapeutics Corporation $42.06 2021-2024 Tyvaso
Abiomed $41.78 2024 Impella
La Jolla Pharmaceutical Company $37.94 2019
Pulmonx Corporation $34.78 2023 Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter
Breas Medical, INC. $32.46 2025 Vivo 45 Ls
Chiesi USA, INC. $31.62 2019-2022
Veran Medical Technologies, INC. $28.28 2020-2021
Gilead Sciences, INC. $24.52 2019-2021
Astellas Pharma US INC $22.65 2022
Bioxcel Therapeutics, INC. $21.63 2023 Igalmi
Ambu INC. $20.20 2022
Tetraphase Pharmaceuticals, INC. $20.19 2019
Abbvie INC. $17.54 2024
Covidien LP $16.76 2019
Nevro Corp. $15.06 2024 Senza
Teva Pharmaceuticals USA, INC. $14.48 2021
Paratek Pharmaceuticals, INC. $11.96 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jeffrey Evans

$20,890.08

in general payments reported 2019-2025

Years
2019-2025
Top company
Intuitive Surgical, INC.
Context
The $3,830 reported for 2025 was more than what 86% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

https://glasscript.com/doctor/2331/jeffrey-evans

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.